SANOFI 80.980 € (+0,43 %) 
ASM INTERNATIONAL 720.000 € (+0,25 %) 
THEON INTERNAT 29.660 € (0,00 %) GTT 187.300 € (+1,46 %) NANOBIOTIX 25.540 € (+0,87 %) TOTALENERGIES 82.710 € (-1,08 %) INVENTIVA 3.550 € (+10,08 %) KERING 180.240 € (+0,32 %) CSG 14.082 € (-1,14 %) PHILIPS KON 25.700 € (+4,81 %) IT LINK 13.700 € (+5,79 %) BAM GROEP KON 12.710 € (+0,16 %) L'OREAL 432.700 € (-0,87 %) ALSTOM 11.125 € (-4,79 %) CEGEDIM 9.630 € (-0,41 %) AIRBUS 193.320 € (-1,41 %) LVMH 401.500 € (+1,99 %) HEINEKEN HOLDING 77.150 € (-0,58 %) ADYEN 827.800 € (-2,75 %) SCHNEIDER ELECTRIC 239.750 € (-0,29 %) STELLANTIS NV 4.084 € (-3,68 %) DANONE 66.020 € (-0,06 %) MAGNUM 17.434 € (-3,27 %) PROSUS 35.270 € (+0,23 %) 
RELX 35.400 € (-1,45 %) SHELL PLC 46.515 € (-1,23 %) PHARMING GROUP 1.134 € (+0,98 %) ORANGE 14.700 € (+1,48 %) ASML HOLDING 1 385.000 € (-1,63 %) AXA 43.050 € (+0,19 %) HEINEKEN 80.840 € (-0,79 %) STMICROELECTRONICS 43.100 € (-0,27 %) BUREAU VERITAS 29.150 € (-0,17 %) EUROCOMMERCIAL 25.000 € (+1,01 %) HAFFNER ENERGY 0.640 € (+5,96 %) CRCAM BRIE PIC2CCI 28.140 € (+2,18 %) BNP PARIBAS ACT.A 87.610 € (+0,65 %) 
MAROC TELECOM 8.160 € (0,00 %) ABN AMRO BANK N.V. 39.770 € (-0,57 %) AMUNDI 92.600 € (-0,43 %) AKZO NOBEL 61.160 € (-1,26 %) TELEPERFORMANCE 80.980 € (-1,34 %) SWORD GROUP 34.450 € (+0,58 %) BE SEMICONDUCTOR 156.100 € (+1,69 %) 
FLOW TRADERS 22.580 € (-0,53 %) ICAPE HOLDING 9.800 € (0,00 %) CTP 12.820 € (+0,79 %) ADP 114.300 € (-0,44 %) MEDINCELL 27.840 € (+3,42 %) VALEO 10.920 € (-3,32 %) ID LOGISTICS GROUP 372.500 € (+0,40 %) CREDIT AGRICOLE 15.020 € (+0,54 %) DASSAULT SYSTEMES 24.980 € (-2,50 %) PUBLICIS GROUPE SA 101.150 € (+0,15 %) ING GROEP N.V. 27.715 € (-1,49 %) CROSSJECT 1.198 € (-4,16 %) SAFRAN 285.000 € (-1,11 %) PERNOD RICARD 68.260 € (-0,96 %) GECINA 64.550 € (-1,22 %) VOPAK 53.150 € (-1,30 %) |
06/10/2026 17:08
EQS-Adhoc: Bio-Gate AG: Revises Revenue and Earnings Forecast for Fiscal Year 2026EQS-Ad-hoc: Bio-Gate AG / Key word(s): Forecast / Half year/Results / Half year Ad hoc announcement pursuant to Art. 17(1) of Regulation (EU) No. 596/2014 (Market Abuse Regulation)
Bio-Gate AG Revises Revenue and Earnings Forecast for Fiscal Year 2026 Nuremberg, October 6, 2026 – The Executive Board of Bio-Gate AG (ISIN DE000BGAG981), a leading provider of proprietary antimicrobial technologies for human and veterinary medicine, decided today to adjust the Group’s revenue and earnings forecast for fiscal year 2026. Two major customers — one for human care products and one for animal care products — have each announced that they will be implementing changes to their product portfolios and organizational restructuring, which will result in significantly lower order volumes, particularly in Bio-Gate AG’s Derma-Cosmetics and Wound Care business segments. The implant coatings business is not affected by these changes.
For the 2026 fiscal year, the Executive Board of Bio-Gate AG now expects consolidated revenue of between 6.0 and 6.9 million euros (previous forecast from May 2026: ±7% of the prior-year level, i.e., approximately 6.9 to 7.9 million euros; prior-year consolidated revenue: 7.4 million euros). EBITDA is expected to range between minus 0.9 and minus 1.1 million euros; despite the lower revenue, this is at or slightly below the prior-year level (minus 0.9 million euros), as cost savings will offset part of the effects of the decline in revenue. Management anticipates EBIT of minus 1.1 to minus 1.5 million euros (previous year: minus 1.1 million euros).
For fiscal year 2027, the Executive Board of Bio-Gate AG anticipates that business with the two major customers will return to positive growth. For example, the dermocosmetics customer plans to launch a new medical device for scar treatment developed and manufactured by Bio-Gate AG. As for the animal care products customer, the existing products will be transitioned into a new product line.
Contact
Bio-Gate AG Falk von Kriegsheim Tel +49 172 9837109 ir@bio-gate.de Neumeyerstr. 28-34 90411 Nürnberg, Germany
End of Inside Information End of Inside Information 06-Oct-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
2411392 06-Oct-2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière